Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
Source:http://linkedlifedata.com/resource/pubmed/id/7594035
J. Am. Coll. Cardiol.
1995
Nov
1
26
5
1222-9
